Search
ProQR Therapeutics NV
PRQRAdd to Watchlist
1.880USD
+0.210+12.57%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
202.50MMarket Cap
LossP/E TTM
ProQR Therapeutics NV's Company Valuation
Currency: USD Updated: 2026-06-17The current valuation score of ProQR Therapeutics NV is 6.34, ranking 343 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.47, which is -55.83% below the recent high of -1.97 and -281.17% above the recent low of -17.03.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
